Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.

Francesca DapportoSerena MarchiMargherita LeonardiPietro PiuPiero LovreglioNicola DecaroNicola BuonvinoAngela StufanoEleonora LorussoEmilio BombardieriAntonella RuelloSimonetta VivianiEleonora MolestiClaudia Maria TrombettaAlessandro ManentiEmanuele Montomoli

Published in: Journal of immunology research (2022)

Repeated vaccination increases antibody avidity against the spike protein of the Omicron variant, suggesting that antibodies with high avidity and high neutralizing potential increase cross-protection against variants that carry several mutations on the RBD.

Keyphrases

sars cov
dengue virus
copy number
risk assessment
gene expression
human health
amino acid
small molecule